Publications by authors named "David Claveau"

Claim this Profile
R
Real-World Effectiveness of Nirmatrelvir-Ritonavir in Preventing Coronavirus Disease 2019-Associated Hospitalization: A Population-Based Cohort Study in the Province of Québec, Canada.
Jean-Luc Kaboré, Benoît Laffont, Mamadou Diop, Melanie R Tardif, Alexis F Turgeon, David Claveau

Clin Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Nirmatrelvir/Ritonavir on Coronavirus Disease 2019-Associated Hospitalization Prevention: A Population-based Cohort Study in the Province of Quebec, Canada.
Jean-Luc Kaboré, Benoît Laffont, Mamadou Diop, Melanie R Tardif, Alexis F Turgeon, David Claveau

Clin Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation-based education to improve management of refractory anaphylaxis in an allergy clinic.
Ana M Copaescu, Francois Graham, Nathalie Nadon, Rémi Gagnon, Arnaud Robitaille, David Claveau

Allergy Asthma Clin Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive detection of a femoral-to-radial arterial pressure gradient in intensive care patients with vasoactive agents.
Matthias Jacquet-Lagrèze, David Claveau, Julie Cousineau, Kun Peng Liu, Jean-Gilles Guimond

J Intensive Care· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications Associated With Nitrate Use in Patients Presenting With Acute Pulmonary Edema and Concomitant Moderate or Severe Aortic Stenosis.
David Claveau, Adam Piha-Gossack, Sayuri N Friedland, Jonathan Afilalo, Lawrence Rudski

Ann Emerg Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Listeria spp. using ACTERO listeria enrichment media.
David Claveau, Sergiy Olishevskyy, Michael Giuffre, Gabriela Martinez

J AOAC Int· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac tamponade due to group a streptococcus descending necrotizing mediastinitis: case report of an unusual presentation.
David Claveau, Marie-Josée Bériault

J Emerg Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is lumbar puncture still needed in suspected subarachnoid hemorrhage after a negative head computed tomographic scan?
David Claveau, Jerrald Dankoff

CJEM· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling following NRF2 and KEAP1 siRNA knockdown in human lung fibroblasts identifies CCL11/Eotaxin-1 as a novel NRF2 regulated gene.
Jimmy Fourtounis, I-Ming Wang, Marie-Claude Mathieu, David Claveau, Tenneille Loo

Respir Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
Alex G Therien, Joann L Huber, Kenneth E Wilson, Patrick Beaulieu, Alexandre Caron, David Claveau

Antimicrob Agents Chemother· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Christopher M Tan, Alex G Therien, Jun Lu, Sang H Lee, Alexandre Caron, David Claveau

Sci Transl Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-frequency transposition for determining antibacterial mode of action.
Hao Wang, David Claveau, John P Vaillancourt, Terry Roemer, Timothy C Meredith

Nat Chem Biol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trisubstituted ureas as potent and selective mPGES-1 inhibitors.
Jean-François Chiasson, Louise Boulet, Christine Brideau, Anh Chau, David Claveau

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors.
André Giroux, Louise Boulet, Christine Brideau, Anh Chau, David Claveau

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors.
Patrick Lacombe, Nathalie Chauret, David Claveau, Stephen Day, Denis Deschênes

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of 8-biarylquinolines: a novel class of PDE4 inhibitors.
Michel Gallant, Nathalie Chauret, David Claveau, Stephen Day, Denis Deschênes

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors.
Bernard Côté, Louise Boulet, Christine Brideau, David Claveau, Diane Ethier

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.
Dwight Macdonald, Anthony Mastracchio, Hélène Perrier, Daniel Dubé, Michel Gallant, David Claveau

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model.
David Claveau, Mirna Sirinyan, Jocelyne Guay, Robert Gordon, Chi-Chung Chan

J Immunol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridazinones as selective cyclooxygenase-2 inhibitors.
Chun Sing Li, Christine Brideau, Chi Chung Chan, Chantal Savoie, David Claveau

Bioorg Med Chem Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-alpha formation with phosphodiesterase 4 (PDE4) selective inhibitors.
Eric S Muise, Ian C Chute, David Claveau, Paul Masson, Louise Boulet

Biochem Pharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis